Chemed Corporation (CHE) Cash Flow Statement

Click line-items for a historical chart and %

Net income	76.55M
Depreciation and amortization
Noncash long-term incentive compensation	837K
Provision for uncollectible accounts receivable	12.13M
Stock option expense	6.26M
Amortization of discount on convertible notes
Provision for deferred income taxes	-5.53M
Increase in accounts receivable	8.06M
Increase in inventories	213K
Increase in prepaid expenses	-1.65M
Increase/(decrease) in accounts payable and other current liabilities	-5.47M
Increase in income taxes	8.59M
Increase in other assets	-5.69M
Increase in other liabilities	6.84M
Excess tax benefit on share-based compensation	-2.97M
Other sources
Net cash provided by operating activities
Capital expenditures	-29.71M
Business combinations, net of cash acquired	0
Other uses	-114K
Net cash used by investing activities
Purchases of treasury stock	-102.31M
Decrease in cash overdrafts payable	2.09M
Proceeds from issuance of capital stock
Dividends paid	-12.22M
Debt issuance costs
Excess tax benefit on share-based compensation	2.97M
Other sources	540K
Net cash used by financing activities
Increase/(Decrease) in Cash and Cash Equivalents	6.56M
Cash and cash equivalents at beginning of year	14.73M
Cash and cash equivalents at end of period	21.29M

Entities mentioned with CHE

View All Entities